调强适形放疗同步化疗治疗复发性宫颈癌的疗效及安全性

发布时间：2018-03-18 07:30

  本文选题：调强适形放疗同步化疗　切入点：复发性宫颈癌　出处：《中国老年学杂志》2017年06期 　论文类型：期刊论文

【摘要】：目的探讨调强适形放疗同步化疗(IMRTCC)治疗复发性宫颈癌的疗效及安全性。方法 88例复发性宫颈癌患者按简单数字随机表法分为观察组及对照组各44例,观察组给予IMRTCC方案治疗,对照组单纯给予常规三维适形放疗,随访6个月,对比两组疗效、不良反应及近期生存率及转移率。结果观察组总有效率明显高于对照组,白细胞下降为Ⅱ~Ⅲ级的发生率明显低于对照组(均P0.05)。两组治疗3、6个月后生存率及转移率比较差异无统计学意义(P0.05)。结论利用IMRTCC对复发性宫颈癌患者进行治疗,具有较高的疗效,且安全性也较好,值得临床应用。
[Abstract]:Objective to investigate the efficacy and safety of IMRT IMRTCC in the treatment of recurrent cervical cancer by intensity modulated conformal radiotherapy (IMRT). Methods 88 patients with recurrent cervical cancer were divided into two groups according to simple digital random table method: the observation group (n = 44) and the control group (n = 44). The control group was treated with conventional three-dimensional conformal radiotherapy and followed up for 6 months to compare the curative effect, adverse reaction, short-term survival rate and metastasis rate. Results the total effective rate in the observation group was significantly higher than that in the control group. The incidence of leukocytopenia in grade 鈪，

本文编号：1628576